Chon, Chae Yoon

Publishing since 1989 (Dinosaur)

Has published 99 publications in 22 years

Number of publications published per year by Chon, Chae Yoon. (Source : PubMed)

Distribution of publications types for Chon, Chae Yoon. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lee HW, Lee HJ, Hwang JS, Sohn JH, Jang JY, Han KJ, Park JY, Kim do Y, Ahn SH, Paik YH, Lee CK, Lee KS, Chon CY, Han KH. Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.  Hepatology  2010;51;2  
•  Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Kim DY. A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis.  Am. J. Gastroenterol.  2010  
•  Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Han KH. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.  Liver Int.  2010  
•  Kim SU, Kim do Y, Lee CK, Park JY, Kim SH, Kim HM, Choi EH, Kim S, Han KH, Chon CY, Ahn SH. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.  J. Gastroenterol. Hepatol.  2010;25;1  
•  Kim SU, Kim do Y, Park JY, Lee JH, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Choi EH, Song KJ, Park YN, Han KH. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?  J. Clin. Gastroenterol.  2010;44;1  
•  Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim DY. External Validation of P2/MS and Comparison with Other Simple Non-invasive Indices for Predicting Liver Fibrosis in HBV-Infected Patients.  Dig. Dis. Sci.  2009  
•  Kim MN, Yoon KT, Park JY, Kim do Y, Ahn SH, Chon CY, Han KH. [A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C]  The Korean journal of hepatology  2009;15;4  
•  Choi JW, Park JY, Ahn SH, Yoon KT, Ko HK, Lee do Y, Lee JT, Kim KS, Choi JS, Han KH, Chon CY, Kim do Y. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.  Am. J. Clin. Oncol.  2009;32;6  
•  Kim SU, Choi GH, Han WK, Kim BK, Park JY, Kim DY, Choi JS, Yang SC, Choi EH, Ahn SH, Han KH, Chon CY. What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea.  Liver Int.  2009  
•  Paik YH, Kim JK, Lee JI, Kang SH, Kim DY, An SH, Lee SJ, Lee DK, Han KH, Chon CY, Lee SI, Lee KS, Brenner DA. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.  Gut  2009;58;11  

[ See timeline ] [ See all publications ]